Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Change in Accured Expenses (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Change in Accured Expenses for 17 consecutive years, with $261000.0 as the latest value for Q1 2026.

  • Quarterly Change in Accured Expenses rose 112.65% to $261000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, up 159.83% year-over-year, with the annual reading at -$1.1 million for FY2025, 254.75% down from the prior year.
  • Change in Accured Expenses for Q1 2026 was $261000.0 at Achieve Life Sciences, up from -$510000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.7 million in Q2 2025, with the low at -$2.1 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $14058.8, with a median of $26000.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses tumbled 3516.67% in 2022, then soared 1692.31% in 2023.
  • Achieve Life Sciences' Change in Accured Expenses stood at -$434000.0 in 2022, then soared by 240.78% to $611000.0 in 2023, then grew by 12.27% to $686000.0 in 2024, then crashed by 174.34% to -$510000.0 in 2025, then skyrocketed by 151.18% to $261000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Change in Accured Expenses are $261000.0 (Q1 2026), -$510000.0 (Q4 2025), and -$1.2 million (Q3 2025).